<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03492879</url>
  </required_header>
  <id_info>
    <org_study_id>SHEBA-17-4351-CTIL</org_study_id>
    <nct_id>NCT03492879</nct_id>
  </id_info>
  <brief_title>Non Invasive Electrical Impedance Technology (EIT) for Diagnosing Liver Diseases Severity</brief_title>
  <official_title>Non Invasive Electrical Impedance Technology (EIT) for Diagnosing Liver Diseases Severity</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Prof. Ziv Ben-Ari MD</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Sheba Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aims of this study are to assess the performance of the non-invasive Electrical Impedance
      Technology (EIT) in evaluating the liver fibrosis stage in patients with chronic liver
      diseases, in comparisons with a liver biopsy and/or Shear wave elastography and Liver
      Ultrasonography.

      The second aim is comparing between Liver Ultrasonography and Electrical Impedance Technology
      (EIT) to quantify the hepatic steatosis grade in patients with Non Alcoholic Fatty Liver
      Disease (NAFLD) .
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The study will include 210 patients with chronic liver diseases. Relevant clinical data such
      as sex, age, weight, height, alcohol intake, medical history and routine lab results will be
      collected.

      The study will include three groups:

        1. Patients with indication for liver biopsy will undergo a routine liver biopsy and also
           routine liver Ultrasonography, Shear wave elastography and Electrical Impedance
           Technology (EIT) (70 patients).

        2. Patients with chronic liver diseases will undergo routine liver Ultrasonography, Shear
           wave elastography and Electrical Impedance Technology (EIT) (70 patients).

        3. Patients with Non Alcoholic Fatty Liver Disease will undergo routine liver
           Ultrasonography, Shear wave elastography and quantification of liver steatosis using the
           Electrical Impedance Technology (EIT) (70 patients).
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">May 15, 2018</start_date>
  <completion_date type="Anticipated">May 30, 2019</completion_date>
  <primary_completion_date type="Anticipated">May 15, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Evaluating the liver fibrosis stage using Electrical Impedance Technology (EIT)</measure>
    <time_frame>Each technology will be performed once in 1 year</time_frame>
    <description>Comparing EIT fibrosis stage result to fibrosis stage result of validated thechnologies</description>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">210</enrollment>
  <condition>Chronic Liver Disease</condition>
  <condition>Fibrosis, Liver</condition>
  <condition>Non-Alcoholic Fatty Liver Disease</condition>
  <arm_group>
    <arm_group_label>Biopsy: Routine tests &amp; EIT Technology</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The patients will undergo a routine liver biopsy and also routine liver Ultrasonography, Shear wave elastography and Electrical Impedance Technology (EIT).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Routine tests &amp; EIT Technology</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The patients will undergo a routine liver Ultrasonography, Shear wave elastography and Electrical Impedance Technology (EIT).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>NASH : Routine tests &amp; EIT Technology</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The patients will undergo a routine liver Ultrasonography, Shear wave elastography and quantification of liver steatosis using the Electrical Impedance Technology (EIT).</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>EIT Technology</intervention_name>
    <description>Electrical Impedance Technology is a non-invasive imaging method who is being tested for evaluation of liver fibrosis stage</description>
    <arm_group_label>Biopsy: Routine tests &amp; EIT Technology</arm_group_label>
    <arm_group_label>Routine tests &amp; EIT Technology</arm_group_label>
    <arm_group_label>NASH : Routine tests &amp; EIT Technology</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with chronic liver diseases

        Exclusion Criteria:

          -  Patients who don't have chronic liver diseases
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ziv Ben-Ari, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Sheba Medical Center</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Avishag Hassid, MA</last_name>
    <phone>+972-35307176</phone>
    <email>avishag.hassid@sheba.health.gov.il</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Ziv Ben-Ari, MD</last_name>
    <phone>+972-35307176</phone>
    <email>ziv.ben-ari@sheba.health.gov.il</email>
  </overall_contact_backup>
  <verification_date>April 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 3, 2018</study_first_submitted>
  <study_first_submitted_qc>April 3, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">April 10, 2018</study_first_posted>
  <last_update_submitted>April 3, 2018</last_update_submitted>
  <last_update_submitted_qc>April 3, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">April 10, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Sheba Medical Center</investigator_affiliation>
    <investigator_full_name>Prof. Ziv Ben-Ari MD</investigator_full_name>
    <investigator_title>Head of liver diseases center</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Liver Diseases</mesh_term>
    <mesh_term>Fatty Liver</mesh_term>
    <mesh_term>Non-alcoholic Fatty Liver Disease</mesh_term>
    <mesh_term>Liver Cirrhosis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

